How effective are COVID-19 vaccines against mild and severe disease?
A new paper in the New England Journal of Medicine reports on the effectiveness of the coronavirus disease 2019 (COVID-19) vaccines in a healthcare setting....
Efficacy
Most Shared
-
-
Vaccine hesitancy and vaccination passports – a Japanese study
A new study from Keio University, Japan, provides an evaluation of the effectiveness of relaxing public interactions following vaccination against the coronavirus disease 2019 (COVID-19)....
-
Adapting biological research and development to COVID-19
In this interview, News-Medical talks to Dr. Yuning Chen, about the work he does with Sino Biological and how they have adapted their research &...
-
Immunogenicity and efficacy of adjuvanted SARS-CoV-2 beta variant subunit booster in rhesus macaques
Mutations in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus have led to the emergence of new and more infectious variants. These variants, classified...
-
Study finds benefits of COVID vaccination in pregnancy outweighs risks
The coronavirus disease 2019 (COVID-19) pandemic increased global morbidity and mortality exponentially over the course of the last two years, with more than five million...
-
Diagnostic sensitivity, viral load and infectivity of SARS-CoV-2 in paired respiratory and oral samples
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has killed millions from coronavirus disease 19 (COVID-19). Retrospective studies indicate that individuals infected with SARS-CoV-2 and...
-
Anti-SARS-CoV-2 antibodies suggested to be safe to use in pregnancy
A recent Mayo Clinic study conducted on pregnant women with mild to moderate coronavirus disease 2019 (COVID-19) has suggested that therapeutic monoclonal antibodies targeting...
-
SARS-CoV-2 omicron variant may evade host immune responses
A recent study conducted at the Medical University of Innsbruck, Austria, has demonstrated that the omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)...
-
Exploring immunogenicity and safety after a homologous booster dose of SARS-CoV-2 recombinant spike protein vaccine
The coronavirus disease 2019 (COVID-19) pandemic started in December 2019 in Wuhan, China, with the spread of the novel severe acute respiratory syndrome coronavirus 2...
-
NeoCura and PhoreMost Announce Research Collaboration to Explore Novel Cancer Therapeutics
NeoCura Bio-Medical Technology Co., Ltd. (“NeoCura”), a leading RNA-based drug research and development company in China, and PhoreMost Limited (PhoreMost), the UK-based biopharmaceutical company dedicated...
-
Nirmatrelvir, Molnupiravir, and Remdesivir hold-up against SARS-CoV-2 Omicron variant in vitro
In a recent study posted to the bioRxiv* preprint server, researchers test three severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antivirals authorized for emergency use...
-
COVID-19 vaccines induce robust cellular immune response against SARS-CoV-2 Omicron
A team of scientists from the United States has recently demonstrated that current coronavirus disease 2019 (COVID-19) vaccines induce robust spike-specific T cell responses against...